Safety and Efficacy of Bleach Baths in Non Critical Hospitalized Patients

May 24, 2021 updated by: Dr. Adrian Camacho-Ortiz, Hospital Universitario Dr. Jose E. Gonzalez

Non critical hospitalized patients were bathed daily with 4 substances: bleach at .005%, bleach at .0125%, clorhexidine 2% and soap and water.

76 patients were enrolled and divided 19 subjects per group. Each patient was cultured with swab technique in palm, antecubital fold and armpit at day 0, day 3 and day 7 of enrollment.

Bacterial cultures were incubated and compared if decolonization occurred. Adverse events were evaluated in all patients.

Only 1 patient had and adverse event and was dry skin. Before patient was enrolled, he had dry skin because of his baseline disease. Moisturizing lotion was applied and patient continue in the study.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

76

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nuevo Leon
      • Monterrey, Nuevo Leon, Mexico, 64460
        • Hospital Universitario José E. Gonzalez

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Non critical hospitalized patients in internal medicine that met inclusion criteria. Subjects should be hospitalized por 1 week.

Description

Inclusion Criteria:

  • Non critical hospitalized patients in internal medicine
  • 18 years old and older

Exclusion Criteria:

  • Burn patients
  • Pregnant women
  • Chloride hypersensitivity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Bleach baths with .0125%
Clorhexidine 2%
Soap and water
Bleach baths with .005%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Safety of Bleach baths as determined by the incidence of adverse or serious adverse events
Time Frame: November 26, 2019 - October 25, 2020
November 26, 2019 - October 25, 2020

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of bacterial colonization from pathogens belonging to the ESKAPE group
Time Frame: November 26, 2019 - October 25, 2020
Identification of colonization by Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species
November 26, 2019 - October 25, 2020
Percentage of patients remaining colonized 3, 5 and 7 days after daily baths
Time Frame: November 26, 2019 - October 25, 2020
November 26, 2019 - October 25, 2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 26, 2019

Primary Completion (Actual)

October 26, 2020

Study Completion (Actual)

October 26, 2020

Study Registration Dates

First Submitted

February 22, 2021

First Submitted That Met QC Criteria

May 24, 2021

First Posted (Actual)

May 27, 2021

Study Record Updates

Last Update Posted (Actual)

May 27, 2021

Last Update Submitted That Met QC Criteria

May 24, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • IF19-00010

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Safety Issues

Subscribe